Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022
Since the severe acute respiratory syndrome outbreak in 2003, China has invested substantial efforts in promoting scientific and technological advances for medical countermeasures against high-threat pathogens. The examination of China’s landscape identifies progress and gaps in research and develo...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2025-01-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/31/1/23-0638_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846110855016480768 |
|---|---|
| author | Jiyan Ma Yang Yang Yangmu Huang |
| author_facet | Jiyan Ma Yang Yang Yangmu Huang |
| author_sort | Jiyan Ma |
| collection | DOAJ |
| description |
Since the severe acute respiratory syndrome outbreak in 2003, China has invested substantial efforts in promoting scientific and technological advances for medical countermeasures against high-threat pathogens. The examination of China’s landscape identifies progress and gaps in research and development (R&D) and also highlights management and regulatory issues that should be of concern to other countries. Our study examined the current state of R&D of medical countermeasures in China during 1990–2022. The findings showed a robust and diversified pipeline responding quickly to disease outbreaks and policy changes. However, proactive and highly innovative candidates are limited, and a large proportion of vaccines and drugs stagnate at the early development stage. A paradigm shift involving a preemptive R&D agenda and persistent investment, innovative technology development, and accelerated research translation is urgently needed to prepare for the next pandemic.
|
| format | Article |
| id | doaj-art-c67c16f4c4bb4bfc8dbf39f066a9d2c2 |
| institution | Kabale University |
| issn | 1080-6040 1080-6059 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj-art-c67c16f4c4bb4bfc8dbf39f066a9d2c22024-12-23T13:52:24ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592025-01-01311142110.3201/eid3101.230638Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022Jiyan MaYang YangYangmu Huang Since the severe acute respiratory syndrome outbreak in 2003, China has invested substantial efforts in promoting scientific and technological advances for medical countermeasures against high-threat pathogens. The examination of China’s landscape identifies progress and gaps in research and development (R&D) and also highlights management and regulatory issues that should be of concern to other countries. Our study examined the current state of R&D of medical countermeasures in China during 1990–2022. The findings showed a robust and diversified pipeline responding quickly to disease outbreaks and policy changes. However, proactive and highly innovative candidates are limited, and a large proportion of vaccines and drugs stagnate at the early development stage. A paradigm shift involving a preemptive R&D agenda and persistent investment, innovative technology development, and accelerated research translation is urgently needed to prepare for the next pandemic. https://wwwnc.cdc.gov/eid/article/31/1/23-0638_articlemedical countermeasuresvaccinesinfectious diseasescommunicable diseasesemerging diseasesresearch and development |
| spellingShingle | Jiyan Ma Yang Yang Yangmu Huang Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022 Emerging Infectious Diseases medical countermeasures vaccines infectious diseases communicable diseases emerging diseases research and development |
| title | Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022 |
| title_full | Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022 |
| title_fullStr | Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022 |
| title_full_unstemmed | Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022 |
| title_short | Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990–2022 |
| title_sort | research and development of medical countermeasures for emerging infectious diseases china 1990 2022 |
| topic | medical countermeasures vaccines infectious diseases communicable diseases emerging diseases research and development |
| url | https://wwwnc.cdc.gov/eid/article/31/1/23-0638_article |
| work_keys_str_mv | AT jiyanma researchanddevelopmentofmedicalcountermeasuresforemerginginfectiousdiseaseschina19902022 AT yangyang researchanddevelopmentofmedicalcountermeasuresforemerginginfectiousdiseaseschina19902022 AT yangmuhuang researchanddevelopmentofmedicalcountermeasuresforemerginginfectiousdiseaseschina19902022 |